Identification of Key Potential Targets and Pathway for Arsenic Trioxide by Systemic Bioinformatics Analysis in Pancreatic Cancer

Arsenic compounds, including various arsenic-containing compounds such as intravenous use of arsenic trioxide (ATO) and an oral tetra-arsenic tetra-sulfide (As4S4) -containing formula named the Realgar-Indigo naturalis formula (RIF). RIF, also known as Compound Huangdai Tablets, which exert anti-tumor effects through a variety of mechanisms, such as the induction of programmed cell death, induction of G1 or G2/M phase arrest, epigenetic regulation of miRNAs, and suppression of cancer stem cell properties. International multicenter clinical studies have shown that ATO and RIF have anti-tumorigenic effects on hematological tumors and some solids. Arsenic compounds also been used in the treatment of cervical cancer, endometrial cancer, ovarian cancer, especially advanced drug-resistant ovarian cancer. This article introduces the progress of ATO in combination chemotherapy, such as ATO with paclitaxel, adriamycin, cisplatin, etc in solid tumors and gynecological malignant tumors. The side effects associated with arsenic treatment, including cardiac disorders, skin and bone marrow suppression, etc. are also discussed in this review. Oral arsenic drugs also have a good therapeutic effect, it may be an outpatient oral chemotherapy new model for RIF to treatment recurrent ovarian cancer.

show abstract

Multimodal approach to characterize the tetrameric form of human PML-RBCC domain and ATO-mediated conformational changes

Dubey

Mishra

Goswami

et al. 2022

International Journal of Biological Macromolecules

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Identification of Key Potential Targets and Pathway for Arsenic Trioxide by Systemic Bioinformatics Analysis in Pancreatic Cancer

Cited by 4 publications

References 38 publications

IDM-SPS: Identifying driver module with somatic mutation, PPI network and subcellular localization

IDM-SPS: Identifying driver module with somatic mutation, PPI network and subcellular localization

Prospect of research and clinical application of arsenic compounds in chemotherapy for gynecological malignant tumors

Multimodal approach to characterize the tetrameric form of human PML-RBCC domain and ATO-mediated conformational changes

Contact Info

Product

Resources

About